Orthofix Medical (OFIX) Common Equity (2009 - 2026)

Orthofix Medical (OFIX) has 18 years of Common Equity data on file, last reported at $435.2 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 5.04% year-over-year to $435.2 million; the trailing twelve-month figure through Mar 2026 stood at $435.2 million (down 5.04% YoY), and the FY2025 full-year result was $450.0 million, down 10.55% from the prior year.
• Common Equity for Q1 2026 stood at $435.2 million, down from $450.0 million in the prior quarter.
• Across five years, Common Equity topped out at $664.2 million in Q1 2023 and bottomed at $333.5 million in Q3 2022.
• A 5-year average of $485.6 million and a median of $458.3 million in 2025 frame the typical range for Common Equity.
• Across the five-year window, Common Equity surged 97.92% in 2023 and fell 19.64% in 2025, its largest moves.
• Tracing OFIX's Common Equity over 5 years: stood at $336.9 million in 2022, then surged by 77.74% to $598.7 million in 2023, then fell by 15.97% to $503.1 million in 2024, then fell by 10.55% to $450.0 million in 2025, then fell by 3.3% to $435.2 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $435.2 million, $450.0 million, and $442.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison